You searched for:"Cristiane Sousa Nascimento Baez"
We found (4) results for your search.-
Special Article
First Brazilian recommendation on physiotherapy with sensory motor stimulation in newborns and infants in the intensive care unit
Rev Bras Ter Intensiva. 2021;33(1):12-30
Abstract
Special ArticleFirst Brazilian recommendation on physiotherapy with sensory motor stimulation in newborns and infants in the intensive care unit
Rev Bras Ter Intensiva. 2021;33(1):12-30
DOI 10.5935/0103-507X.20210002
Views2Abstract
Objective:
To present guidelines on sensory motor stimulation for newborns and infants in the intensive care unit.
Methods:
We employed a mixed methods design with a systematic review of the literature and recommendations based on scientific evidence and the opinions of physiotherapists with neonatal expertise. The research included studies published between 2010 and 2018 in the MEDLINE® and Cochrane databases that included newborns (preterm and term) and infants (between 28 days and 6 months of age) hospitalized in the intensive care unit and submitted to sensory motor stimulation methods. The studies found were classified according to the GRADE score by five physiotherapists in different regions of Brazil and presented at eight Scientific Congresses held to discuss the clinical practice guidelines.
Results:
We included 89 articles to construct the clinical practice guidelines. Auditory, gustatory and skin-to-skin stimulation stand out for enhancing vital signs, and tactile-kinesthetic massage and multisensory stimulation stand out for improving weight or sucking.
Conclusion:
Although all modalities have good ratings for pain or stress control, it is recommended that sensory motor stimulation procedures be tailored to the infant’s specific needs and that interventions and be carried out by expert professionals.
Keywords:Child developmentInfantInfant, newbornIntensive care units, neonatalNeuropsychomotor developmentPsychomotor performanceSensory motor stimulationSee more -
Review Articles
Controversies involving hypercapnic acidosis in acute respiratory distress syndrome
Rev Bras Ter Intensiva. 2009;21(4):404-415
Abstract
Review ArticlesControversies involving hypercapnic acidosis in acute respiratory distress syndrome
Rev Bras Ter Intensiva. 2009;21(4):404-415
DOI 10.1590/S0103-507X2009000400011
Views0See moreAcute respiratory distress syndrome is characterized by a diffuse inflammatory reaction of lung parenchyma induced by a direct insult to the alveolar epithelium (pulmonary acute respiratory distress syndrome) or an indirect lesion through the vascular endothelium (extrapulmonary acute respiratory distress syndrome). The main therapeutic strategy for acute respiratory distress syndrome is the ventilatory support. However, mechanical ventilation can worsen lung injury. In this context, a protective ventilatory strategy with low tidal volume has been proposed. The use of low tidal volume reduced the mortality rate of acute respiratory distress syndrome patients, but result in hypercapnic acidosis. The current article presents a review of literature on the effects of permissive hypercapnia in acute respiratory distress syndrome. To that end, we carried out a systematic review of scientific literature based on established criteria for documental analysis including clinical and experimental articles, using as data bases MedLine, LILACS, SciELO, PubMed, Cochrane. Hypercapnic acidosis has been considered by some authors as a modulator of the inflammatory process of acute respiratory distress syndrome. However, clinical and experimental studies on the effects of hypercapnic acidosis have shown controversial results. Therefore it is important to better elucidate the role of hypercapnic acidosis in acute respiratory distress syndrome.
-
Review Articles
Stem cell therapy in acute respiratory distress syndrome
Rev Bras Ter Intensiva. 2009;21(1):51-57
Abstract
Review ArticlesStem cell therapy in acute respiratory distress syndrome
Rev Bras Ter Intensiva. 2009;21(1):51-57
DOI 10.1590/S0103-507X2009000100008
Views0See moreAcute respiratory distress syndrome is characterized by an acute pulmonary inflammatory process induced by the presence of a direct (pulmonary) insult that affects lung parenchyma, or an indirect (extrapulmonary) insult that results from an acute systemic inflammatory response. It is believed that an efficient therapy for the acute respiratory distress syndrome should attenuate inflammatory response and promote adequate repair of the lung injury. This article presents a brief review on the use of stem cells and their potential therapeutic effect on the acute respiratory distress syndrome. This systematic review was based upon clinical and experimental acute respiratory distress syndrome studies included in the MedLine and SciElO database during the last 10 years. Stem cell transplant lead to an improvement in lung injury and fibrotic process by inducing adequate tissue repair. This includes alveolar epithelial cell differentiation,and also reduces pulmonary and systemic inflammatory mediators and secretion of growth factors. Stem cells could be a potential therapy for acute respiratory distress syndrome promoting lung repair and attenuating the inflammatory response. However, mechanisms involving their anti-inflammatory and antifibrinogenic effects require better elucidation, limiting their immediate clinical use in acute respiratory distress syndrome.
Search
Search in:
KEY WORDS
Case reports Child Coronavirus infections COVID-19 Critical care Critical illness Extracorporeal membrane oxygenation Infant, newborn Intensive care Intensive care units Intensive care units, pediatric mechanical ventilation Mortality Physical therapy modalities Prognosis Respiration, artificial Respiratory insufficiency risk factors SARS-CoV-2 Sepsis